Poor medication adherence is a pervasive issue with considerable health and
socioeconomic consequences. Although the underlying reasons are generally understood …

There has been a revolution in nanotechnology and nanomedicine. Since 1980, there has
been a remarkable increase in approved nano-based pharmaceutical products. These novel …

Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

OBJECTIVE:: In the intent-to-treat analysis of the Multimodal Treatment Study of Children
With ADHD (MTA), the effects of medication management (MedMgt), behavior therapy (Beh) …

This paper presents evidence that diagnoses of attention-deficit/hyperactivity disorder
(ADHD) are driven largely by subjective comparisons across children in the same grade in …

INTRODUCTION: This meta-analysis compares effect-sizes of methylphenidate and
psychosocial treatments and their combination on ADHD, concurrent oppositional, conduct …

A systematic review of published and unpublished data on the use of long-acting
medications in ADHD and hyperkinetic disorder is reported, giving effect sizes and numbers …

This study aimed to establish the psychometric properties of parent ratings on the Chinese
version of the Swanson, Nolan, and Pelham IV scale (SNAP‐IV) in a school‐based sample …

Background Children with autistic spectrum disorder (ASD) frequently present with
inattention, impulsivity and hyperactivity, which are the cardinal symptoms of attention deficit …

Safe and effective medication for attention deficit hyperactivity disorder (ADHD) is available
and recommended as first-line treatment for the core symptoms of inattention, overactivity …